Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings

@article{Pelletier2018RecurrenceON,
  title={Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings},
  author={Jonathan H. Pelletier and Karan R. Kumar and Rachel M. Engen and Adam Bensimhon and Jennifer D. Varner and Michelle N. Rheault and Tarak Srivastava and Caroline Straatmann and Cynthia Silva and Thomas Keefe Davis and Scott E. Wenderfer and Keisha Gibson and David T. Selewski and John P Barcia and Patricia L Weng and Christoph Licht and Natasha A. Jawa and Mahmoud Kallash and John W. Foreman and Delbert R. Wigfall and Annabelle N Chua and Eileen T Chambers and Christoph P. Hornik and Eileen D. Brewer and Shashi K. Nagaraj and Larry A. Greenbaum and Rasheed A. Gbadegesin},
  journal={Pediatric Nephrology},
  year={2018},
  volume={33},
  pages={1773-1780}
}
Background and objectivesSteroid-resistant nephrotic syndrome (SRNS) due to focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) is a leading cause of end-stage kidney disease in children. Recurrence of primary disease following transplantation is a major cause of allograft loss. The clinical determinants of disease recurrence are not completely known. Our objectives were to determine risk factors for recurrence of FSGS/MCD following kidney transplantation and factors that… 

Response to Steroid and Immunosuppressive Therapies May Predict Post-transplant Recurrence of Focal Segmental Glomerulosclerosis

It is suggested that the response to steroid treatment, other immunosuppressive agents, and/or plasmapheresis may predict post-transplant FSGS recurrence.

Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience

Absence of a causative mutation represents the major risk factor for post-transplant recurrence in children with SRNS, while transplant can be curative in genetic SRNS.

HLA Loci and Recurrence of Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplantation

HLA profiles may be used for risk stratification of recurrence of FSGS in pediatric kidney transplant recipients and deserves further study.

Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid‐resistant nephrotic syndrome

The educated statements presented here acknowledge that FSGS/SRNS recurrence after pediatric RTx remains a major concern and is associated with shorter graft survival or even graft loss, and the value of any recommendation needs to take into account that evidence is based on cohorts that differ in ethnicity, pre‐transplant history, immunosuppressive regimen, definition of recurrence (eg, clinical and/or histological diagnosis) and treatment modalities ofRecurrence.

Impact of initial steroid response on transplant outcomes in children with steroid-resistant nephrotic syndrome

Secondary steroid resistance is strongly associated with SRNS recurrence and atopy and hypoalbuminaemia at transplant may be novel risk factors for recurrence.

IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome

A team of experts including pediatric nephrologists and renal geneticists from the International Pediatric Nephrology Association, a renal pathologist, and an adult nephrologyist have now developed comprehensive clinical practice recommendations on the diagnosis and management of steroid-resistant nephrotic syndrome in children.

Prospects of genetic testing for steroid-resistant nephrotic syndrome in Nigerian children: a narrative review of challenges and opportunities

The genetics of NS/SRNS in childhood is described and a narrative review of the challenges and opportunities for molecular testing among children with SRNS in Nigeria is given.

International Pediatric Nephrology Association (2020). IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatric Nephrology, (2020). https://doi.org/10.1007/s00467-020-04519-1

A team of experts including pediatric nephrologists and renal geneticists from the International Pediatric Nephrology Association, a renal pathologist, and an adult nephrologyist have developed comprehensive clinical practice recommendations on the diagnosis and management of steroid-resistant nephrotic syndrome in children.

Case Report: Novel Dietary Supplementation Associated With Kidney Recovery and Reduction in Proteinuria in a Dialysis Dependent Patient Secondary to Steroid Resistant Minimal Change Disease

Intradialytic parenteral nutrition, albumin infusion along with a proprietary dietary supplement, as part of the supportive therapy, led to kidney function recovery and complete remission of Minimal Change Disease without relapses.

Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children

Administration of concomitant treatments during rituximab-mediated B cell depletion, such as methylprednisolone pulse therapy, daily oral prednisol one therapy, and immunosuppressive agents, may lead to better outcomes in patients with refractory SRNS.

References

SHOWING 1-10 OF 43 REFERENCES

Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis.

  • H. I. CheongH. Han Y. Choi
  • Medicine
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2000
The results support more liberal use of living-related donors for renal transplantation of children with FSGS and ESRD, considering the shortage of cadaveric donors in the authors' society and relatively good efficacy of the early and intensive PE+CPM therapy for early recurrent nephrotic syndrome.

Recurrent focal segmental glomerulosclerosis after kidney transplantation

Recent advances in the epidemiology, pathophysiology, and treatment of recurrent FSGS in pediatric patients who have received a kidney transplant are summarized.

Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis.

It is proposed that live donor transplantation should not be avoided in patients withFSGS, and graft survival in live donor recipients was significantly better for both children and adults with FSGS.

Focal Segmental Glomerulosclerosis in Children: Multivariate Analysis Indicates That Donor Type Does Not Alter Recurrence Risk

FSGS as a cause of pediatric end-stage renal disease leading to transplantation is on the rise, and FSGS recurrence is highest in young, white children, whereas receiving a LD kidney is not independently associated with increased risk of recurrence.

Genetics of childhood steroid-sensitive nephrotic syndrome

What is currently known about the genetics of SSNS is reviewed and how recent careful phenotypic and genomic studies reinforce the role of adaptive immunity in the molecular mechanisms ofSSNS is discussed.

Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study.

The recurrence rate was similar in white children when compared with that in Hispanic children but was lower than that in black children, and the mean serum albumin level of patients with recurrence was 1.7 versus 2.0 g/dL for those without recurrence.

Causes and pathogenesis of focal segmental glomerulosclerosis

  • A. Fogo
  • Medicine, Biology
    Nature Reviews Nephrology
  • 2015
The recurrence of FSGS in some transplant recipients whose end-stage renal disease was caused by FSGS points to circulating factors in disease pathogenesis, which remain incompletely understood.

Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years’ experience

Early PP implementation should be considered after KT for 1◦ FSGS patients with early graft dysfunction despite delayed proteinuria and nonspecific biopsy, as well as for non‐rFSGS, r FSGS, and 2◦FSGS grafts, respectively.